{"schema_version":"1","generated_at":"2026-11-11T01:18:05.203Z","data_as_of":null,"url":"https://www.findmykol.com/kol/steven-borson","json_url":"https://www.findmykol.com/kol/steven-borson/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"steven-borson","name":"Steven Borson","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1477968998","orcid":"0000-0002-7690-4087","openalex":"A5090910814"},"summary":"Steven Borson is an Oncology physician. OpenAlex indexes 14 publications with 328 citations (h-index 5).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":14,"cited_by_count":328,"h_index":5,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"Incyte Corporation","program_year":2025,"amount_usd":124.99,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1477968998"},{"payer":"Bayer Healthcare Pharmaceuticals Inc.","program_year":2025,"amount_usd":23.2,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1477968998"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":17.16,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1477968998"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1477968998","source":"payments"},"prescribing":{"data_year":2024,"areas_total":8,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":33.9,"classes_total":3,"classes":[{"class":"Thalidomide Analog","setting":"prescribed","share_pct":17.1,"drugs":[{"name":"Revlimid","share_pct":64},{"name":"Lenalidomide","share_pct":36}],"max_beneficiaries":null},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":10.6,"drugs":[{"name":"Calquence","share_pct":54.8},{"name":"Brukinsa","share_pct":45.2}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":18.5,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":18.5,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":19}]},{"area":"Anti-infectives","share_pct":12.7,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":12.7,"drugs":[{"name":"Valacyclovir","share_pct":100}],"max_beneficiaries":12}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":20.1,"facility_pct":79.9},"source":"medicare"},"publications":{"total":14,"shown":5,"withheld":9,"matched_by":"OpenAlex author record","recent":[{"title":"Outcomes for female patients with multiple myeloma: A national retrospective trend analysis from 2015 to 2022","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-8119","status":"verified"},{"title":"Outcomes for Medicaid recipients with multiple myeloma: A national retrospective trend analysis from 2015 to 2022","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-8117","status":"verified"},{"title":"Outcomes for low-income patients with multiple myeloma: A national retrospective trend analysis from 2015 to 2022","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-6373","status":"verified"},{"title":"Outcomes for black persons with multiple myeloma: A national retrospective trend analysis from 2015 to 2022","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-2821","status":"verified"},{"title":"Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis","year":2022,"journal":"Laryngoscope Investigative Otolaryngology","source_url":"https://doi.org/10.1002/lio2.807","status":"verified"}],"source":"works"},"contact":{"address_1":"150 S HUNTINGTON AVE","city":"Boston","state":"MA","zip":"021304817","phone":"617-232-9500","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1477968998","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":2,"publications":9}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-05-15","provider_certified":"2023-05-15","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}